Erythro-Med 115.6 mg Powder For Solution is a Health Canada–registered veterinary drug (DIN 02030578) held by Bio Agri Mix Lp, containing Erythromycin (Erythromycin Phosphate). Health Canada lists its status as Cancelled Post Market (status date 07 Jun 2022). Nexara Health has matched 478 registrations of Erythromycin (Erythromycin Phosphate) across 27 other regulated markets.
Health Canada registration
| DIN | 02030578 |
|---|---|
| Brand name | Erythro-Med |
| Active ingredient | Erythromycin (Erythromycin Phosphate) |
| Strength | 115.6 mg |
| Dosage form | Powder For Solution |
| Route | Oral |
| Company | Bio Agri Mix Lp |
| Status | Cancelled Post Market — 07 Jun 2022 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Erythromycin (Erythromycin Phosphate) registered in other markets
478 registrations of the same molecule in 27 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | E-Mycin 200 | Af | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | GE | PBS | |
| Australia | E-Mycin 200 | Af | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | GE | PBS | |
| Australia | E-Mycin 400 | Af | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | GE | PBS | |
| Australia | E-Mycin 400 | Af | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | GE | PBS | |
| Australia | Mayne Pharma Erythromycin | Yt | Capsule 250 mg (containing enteric coated pellets) | GE | PBS | |
| Australia | Mayne Pharma Erythromycin | Yt | Capsule 250 mg (containing enteric coated pellets) | GE | PBS | |
| Australia | Mayne Pharma Erythromycin | Yt | Capsule 250 mg (containing enteric coated pellets) | GE | PBS | |
| Australia | Mayne Pharma Erythromycin | Yt | Capsule 250 mg (containing enteric coated pellets) | GE | PBS | |
| Austria | Erythrocin Lactobionat 1,0 g Trockensubst. z. Inf.bereitung | — | 1St | green box | eEKO (Erstattungskodex) | |
| Bahrain | Erocin | Amman Pharmaceutical Industries, Jordan. | 0.5 % | Eye Ointment | POM | NHRA |
| Bahrain | Omathrocin | National Pharmaceutical Industries Co. "Saoc" (Npi), Oman. | 250 MG | Tablet | POM | NHRA |
| Bahrain | Omathrocin | National Pharmaceutical Industries Co. "Saog" (Npi), Oman. | 100 MG/2.5ML | Oral Drops | POM | NHRA |
| Bahrain | Omathrocin | National Pharmaceutical Industries Co. "Saog" (Npi), Oman. | 250 MG | Tablet | POM | NHRA |
| Bahrain | Omathrocin 200 | National Pharmaceutical Industries Co. "Saog" (Npi), Oman. | 200 MG/5ML | Powder For Oral Suspension | POM | NHRA |
| Bulgaria | Davercin | Tarchomin Pharmaceutical Works "Polfa" S.A. | 25 mg/g gel | гел | По лекарско предписание | BDA |
| Czech Republic | Aknemycin | — | 20MG/G | Ung | R | SUKL DLP |
| Czech Republic | Aknemycin | — | 20MG/G | Drm Sol | R | SUKL DLP |
| Czech Republic | Zineryt | — | 40MG/ML+12MG/ML | Drm Plq Sol | R | SUKL DLP |
| Denmark | Abboticin | Amdipharm Limited | 250 mg | filmovertrukne tabletter | National | Laegemiddelstyrelsen |
| Denmark | Abboticin | Amdipharm Limited | 500 mg | filmovertrukne tabletter | National | Laegemiddelstyrelsen |
| Denmark | Abboticin | Amdipharm Limited | 40 mg/ml | granulat til oral suspension | National | Laegemiddelstyrelsen |
| Denmark | Abboticin | Amdipharm Limited | 1 g | pulver til infusionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Abboticin | Amdipharm Limited | 100 mg/ml | granulat til oral suspension | National | Laegemiddelstyrelsen |
| Denmark | Abboticin Novum | Amdipharm Limited | 500 mg | filmovertrukne tabletter | National | Laegemiddelstyrelsen |
| Denmark | Erythromycin "Panpharma" | Panpharma | 500 mg | pulver til infusionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Erythromycin "Panpharma" | Panpharma | 1 g | pulver til infusionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Greece | Acmefront® Cut.sol (40+0.25)mg/mL Bt X 1 Bottle X 50ml (Πλαστικη Φιαλη Με Ειδικο Σταγονομετρικο Ρυγχος) | Verisfield Μονοπροσωπη Α.ε. Δ.τ. Verisfield | reimbursed | MoH deltio timwn | ||
| Greece | Acmefront® Gel (40+0.25)mg/g Bt X 1 Tube X 50g Σωληναριο Απο Συμπιεσμενο Αλουμινιο Με Εσωτερικη Επιστρωση Ρητινης Εποξυφαινολικου Τυπου Με Βιδωτο Πωμα Απο Λευκο Πολυπροπυλενιο | Verisfield Μονοπροσωπη Α.ε. Δ.τ. Verisfield | reimbursed | MoH deltio timwn | ||
| Greece | ACNE HERMAL CUT.SOL 1,63%(W/V)η2%(W/W) FLx25 ML | Galenica Αε | non-reimbursed | MoH deltio timwn | ||
| Greece | ACNERYZ-CURE® GEL.EXT.US (4.0+1.2)% w/w ΒΤ x 2 tubes x 20 gr+1 plastic jar+1 plastic spatula | Nassington Ltd, Cyprus | reimbursed | MoH deltio timwn | ||
| Greece | Dankit Gel.ext.us 4% Tubx30g | Rafarm A.e.b.e. | reimbursed | MoH deltio timwn | ||
| Greece | ERYBENZ GEL (5+3)% W/W BTx2 TUBx20 GR +1 EMPTY JAR +1 EMPTY JAR | Verisfield Μονοπροσωπη Α.ε. Δ.τ. Verisfield | reimbursed | MoH deltio timwn | ||
| Greece | ERYTIN-ACN CUT.SOL (4.0+0.025)% W/V BTx1 BOTTLE x 50 ML | Doc Pharma Ανωνυμη Εταιρεια Δ.τ. Doc Pharma Ae | reimbursed | MoH deltio timwn | ||
| Greece | ERYTIN-ACN GEL.EXT.US (4.0+0.025)% W/W BTx1 TUBE x 50 G | Doc Pharma Ανωνυμη Εταιρεια Δ.τ. Doc Pharma Ae | reimbursed | MoH deltio timwn | ||
| Hong Kong | Apo-Erythro-Base Tab 250mg | Hind Wing Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Eryacne Gel 4% | Galderma Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Erymed Cream 2%W/W | Healthcare Pharmascience Limited | Registered | DH Drug Office | ||
| Hong Kong | Erythrobase Tab 250mg Enteric-Coated | Europharm Lab Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Erythromycin | Sunrise Trading Co | Registered | DH Drug Office | ||
| Iceland | Abboticin | Icepharma - óskráð | 250 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Davercin | Parlogis - óskráð lyf | 250 mg | filmhtfl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Erythrocine | Icepharma - óskráð | 250 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Erythrocine | Parlogis - óskráð lyf | 1 g | sts | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Erythromycin | Parlogis - óskráð lyf | 1 g | sts | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Infectomycin | Parlogis - óskráð lyf | 400 mg/5ml | mixtduft | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Infectomycin | Parlogis - óskráð lyf | 400 mg/5ml | mixtduft | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Erythrocin 250 mg tablets | Amdipharm Limited | Film-coated tablet | Marketed | HPRA | |
| Ireland | Erythrocin 500 mg tablets | Amdipharm Limited | Film-coated tablet | Marketed | HPRA | |
| Ireland | Erythrocin IV Lactobionate 1 g Powder for Concentrate for Solution for Infusion | Amdipharm Limited | Powder for concentrate for solution for infusion | Marketed | HPRA | |
| Ireland | Erythroped Adult 500mg Film-coated Tablets | Amdipharm Limited | Film-coated tablet | Not marketed | HPRA | |
| Ireland | Erythroped PI SF 125 mg/5 ml granules for oral suspension | Amdipharm Limited | Granules for oral suspension | Not marketed | HPRA | |
| Ireland | Erythroped SF 250 mg/5 ml granules for oral suspension | Amdipharm Limited | Granules for oral suspension | Not marketed | HPRA | |
| Ireland | Primacine 125 mg/5 ml Granules for Oral Suspension | Pinewood Laboratories Ltd | Granules for oral suspension | Marketed | HPRA | |
| Ireland | Primacine 250 mg/5 ml Granules for Oral Suspension | Pinewood Laboratories Ltd | Granules for oral suspension | Marketed | HPRA | |
| Lebanon | Erythromycin 1.5 % | Mediphar Laboratories | 15mg/ml | Solution | A1 | MoPH |
| Luxembourg | Aknemycin POMM. 2 PC 1*1 tube alu. 25 g | — | RR | CNS liste positive | ||
| Luxembourg | Aknemycin SOL.APP.CUT 2 PC 1*1 flacon verre 25 mL | — | RR | CNS liste positive | ||
| Luxembourg | Erythrocine GRAN.SP.BUV. 250 mg / 5 mL 1*1 flacon HDPE 80 mL | — | RR | CNS liste positive | ||
| Luxembourg | ERYTHROCINE IV PDRE SOL.PERF. 1 g 1*1 FIOLE | — | RR | CNS liste positive | ||
| Luxembourg | Erythroforte 500 CPR.ENROB. 500 mg 1*16 CPR.(flacon) | — | RR | CNS liste positive | ||
| Luxembourg | ERYTHROMYCINE-BAILLEUL SOL.APP.CUT 4 PC 1*1 flacon 100 mL | — | RR | CNS liste positive | ||
| Luxembourg | ZINERYT PSV.SOL.CU 40 mg / 1 mL + 12 mg / 1 mL 1*1 flacon solvant 30 mL + 1*1 flacon poudre | — | RR | CNS liste positive | ||
| Malaysia | Axcel Erythromycin Es Tablet | Kotra Pharma (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Axcel Erythromycin Es-200 Suspension | Kotra Pharma (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Axcel erythromycin ES-400 Suspension | Kotra Pharma (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Dyna Erythromycin Tablet | Dynapharm (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Elthrocin Tablet 250mg | Sm Pharmaceuticals Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Elthrocin Tablet 500mg | Sm Pharmaceuticals Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Eomycin Granules 200mg/5ml | Teraputics Sdn Bhd | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Ericin For Oral Suspension 200mg/5ml | Inspirapharma Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malta | Erythrocin I.V. Lactobionate / Erythromycin Lactobionate 1g Powder for Solution for Infusion | Central Procurement & Supplies Unit | Powder For Solution For Infusion | Authorised | Medicines Authority | |
| Malta | Primacine 250 mg/5 ml Granules for Oral Suspension | Pinewood Laboratories Limited | Granules For Oral Suspension | Authorised | Medicines Authority | |
| Netherlands | Erythrocine I.V., poeder voor oplossing voor infusie 1 g | Amdipharm Limited | Poeder voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Erythromycine Eureco-Pharma i.v. 1 g poeder voor oplossing voor infusie | Eureco-Pharma B.V. | Poeder voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Erytromycine Eureco-Pharma i.v. 1 g poeder voor oplossing voor infusie | Eureco-Pharma B.V. | Poeder voor oplossing voor infusie | Uitsluitend recept | EU national register | |
| Netherlands | Inderm 10 mg/g, applicatievloeistof | Euro Registratie Collectief B.V. | Oplossing voor cutaan gebruik | Uitsluitend recept | EU national register | |
| Netherlands | Inderm, applicatievloeistof 1% | Centrafarm B.V. | Oplossing voor cutaan gebruik | Uitsluitend recept | EU national register | |
| Norway | Abboticin granulat til mikst, susp 100 mg/ml | Amdipharm Limited | 100 | Granulat til mikstur, suspensjon | Aktiv oppføring | FEST (DMP) |
| Norway | Abboticin pulv til inf væske oppl 1 g | Amdipharm Limited | 1 | Pulver til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Abboticin pulv til inf væske oppl 1 g | Amdipharm Limited (1) | 1 | Pulver til infusjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Abboticin tab 250 mg | Amdipharm Limited | 40 | Tablett | Aktiv oppføring | FEST (DMP) |
| Norway | Abboticin tab 250 mg | Amdipharm Limited | 30 | Tablett | Aktiv oppføring | FEST (DMP) |
| Norway | Abboticin tab 250 mg | Amdipharm Limited | 100 | Tablett | Aktiv oppføring | FEST (DMP) |
| Norway | Ery-Max granulat til mikst, susp 100 mg/ml | Viatris AS | 100 | Granulat til mikstur, suspensjon | Aktiv oppføring | FEST (DMP) |
| Norway | Ery-Max granulat til mikst, susp 100 mg/ml | Viatris AS | 50 | Granulat til mikstur, suspensjon | Aktiv oppføring | FEST (DMP) |
| Poland | Aknemycin | Almirall Hermal GmbH | 20 mg/g | Płyn do stosowania na skórę | Bezterminowe | URPL RPL |
| Poland | Aknemycin | Medezin Sp. z o.o. | 20 mg/g | Maść | 2029-10-18 | URPL RPL |
| Poland | Aknemycin | Almirall Hermal GmbH | 20 mg/g | Maść | Bezterminowe | URPL RPL |
| Poland | Aknemycin | InPharm Sp. z o.o. | 20 mg/g | Maść | 2030-09-07 | URPL RPL |
| Poland | Aknemycin | Delfarma Sp. z o.o. | 20 mg/g | Maść | 2026-01-19 | URPL RPL |
| Poland | Aknemycin | Medezin Sp. z o.o. | 20 mg/g | Maść | 2030-10-09 | URPL RPL |
| Poland | Aknemycin | InPharm Sp. z o.o. | 20 mg/g | Płyn na skórę | 2028-03-28 | URPL RPL |
| Poland | Aknemycin | Medezin Sp. z o.o. | 20 mg/g | Płyn na skórę | 2030-03-13 | URPL RPL |
| Romania | ERITROMICINA ATB 200 mg | — | 200mg | Compr. | PRF | ANMDMR nomenclator |
| Romania | ERITROMICINA ATB 200 mg | — | 200mg | Compr. | PRF | ANMDMR nomenclator |
| Saudi Arabia | Eromycin 200mg-5ml Susp | — | 40 | Inactive | SFDA | |
| Saudi Arabia | Eromycin 250mg Tablet | — | 250 | Inactive | SFDA | |
| Saudi Arabia | Eryc 250mg Caps | — | 250 | Inactive | SFDA | |
| Saudi Arabia | Eryderm For Topical Soln 2% | — | 2 | Inactive | SFDA | |
| Saudi Arabia | Eryped For Oral Soln 400mg-5ml | — | 80 | Inactive | SFDA | |
| Saudi Arabia | Erysol 2% Topical Lotion | — | 2 | Inactive | SFDA | |
| Saudi Arabia | Erythrocin Granules 200mg-5ml | — | 40 | Inactive | SFDA | |
| Saudi Arabia | Erythrocin Granules 200mg-5ml | — | 40 | Inactive | SFDA | |
| Singapore | ERMYCIN 250 TABLET 250 mg | Goldplus Universal Pte Ltd | 250 mg | Tablet, Film Coated | Prescription Only | HSA |
| Singapore | ERYCYN-250 TABLET 250 mg | Naina Mohamed & Sons Private Limited | 250 mg | Tablet, Film Coated | Prescription Only | HSA |
| Singapore | ERYSOL FOR ORAL SUSPENSION 200 mg/5 ml | Apex Pharma Marketing Pte. Ltd. | 200 mg/5 ml | Granule, For Suspension | Prescription Only | HSA |
| Singapore | Eryson Lotion 2% | Beacons Pharmaceuticals Pte. Ltd. | 2% w/v | Lotion | Prescription Only | HSA |
| Singapore | ERYSON TABLETS 250 mg | Beacons Pharmaceuticals Pte. Ltd. | 250 mg | Enteric Coated Tablet | Prescription Only | HSA |
| Singapore | RETORIN POWDER FOR SUSPENSION 200 mg/5 ml | Uni Drug House | 200 mg/5 ml | Powder, For Suspension | Prescription Only | HSA |
| Slovakia | Aknemycin 2000 | Pos-D | ung 1x25 g (tuba Al) | O | MZ SR kategorizacia | |
| Slovakia | Eryfluid | Pfb-Fr-1 | sol der 1x100 ml (fľ.skl.hnedá) | O | MZ SR kategorizacia | |
| South Africa | Adco Erythromycin Capsules | Adcock Ingram Limited | 250 mg | Cap | S4 | DoH SEP database |
| South Africa | Adco Erythromycin Capsules | Adcock Ingram Limited | 250 mg | Cap | S4 | DoH SEP database |
| South Africa | Betamycin | Be Tabs Pharmaceuticals (Pty) Ltd | 250 mg | Tab | S4 | DoH SEP database |
| South Africa | Betamycin Granules 125 mg | Ranbaxy Pharmaceuticals (Pty) Ltd | 125 mg/5ml | Sus | S4 | DoH SEP database |
| South Africa | Eryderm Top Soln 60ml | Abbott Laboratories SA (Pty) Ltd | 1200 mg/60ml | Lot | S4 | DoH SEP database |
| South Africa | Eryko-250 | Dezzo Trading 392 (Pty) Limited T/A Indo Pharma | 250 mg | Tab | S4 | DoH SEP database |
| South Africa | Eryko-250 | Dezzo Trading 392 (Pty) Limited T/A Indo Pharma | 250 mg | Tab | S4 | DoH SEP database |
| South Africa | Erymycin Af | Pharmacare Limited, Woodmead | 250 mg | Cap | S4 | DoH SEP database |
| Taiwan | Dafree Ointment 1% "Swiss"(Erythromycin) | 瑞士藥廠股份有限公司新市廠 | 軟膏劑 | Registered | TFDA |
See every manufacturer of Erythromycin (Erythromycin Phosphate) worldwide →
Regulator price references for Erythromycin (Erythromycin Phosphate)
Published list or reimbursement prices for Erythromycin (Erythromycin Phosphate) presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | E-Mycin 200 | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | 4.46 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | E-Mycin 200 | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | 4.46 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | E-Mycin 400 | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | 5.68 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | E-Mycin 400 | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | 5.68 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Mayne Pharma Erythromycin | Capsule 250 mg (containing enteric coated pellets) | 11.16 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Mayne Pharma Erythromycin | Capsule 250 mg (containing enteric coated pellets) | 11.16 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Mayne Pharma Erythromycin | Capsule 250 mg (containing enteric coated pellets) | 11.16 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Mayne Pharma Erythromycin | Capsule 250 mg (containing enteric coated pellets) | 11.16 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Erythrocin Lactobionat 1,0 g Trockensubst. z. Inf.bereitung | 1000mg | 1St | 13.70 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Omathrocin | 100mg/2.5ml | 30ML | 0.58 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Omathrocin 200 | 200mg/5ml | 100ML | 0.69 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Erocin | 0.5pct | 5G | 0.92 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Omathrocin | 250mg | 20 | 0.93 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Omathrocin | 250mg | 1000 | 36.02 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | ACNE HERMAL CUT.SOL 1,63%(W/V)η2%(W/W) FLx25 ML | 1.63pct+25ml+2pct | 2.68 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Dankit Gel.ext.us 4% Tubx30g | 30000mg+4pct | 4.21 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ERYBENZ GEL (5+3)% W/W BTx2 TUBx20 GR +1 EMPTY JAR +1 EMPTY JAR | 11.30 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | ||
| Greece | ACNERYZ-CURE® GEL.EXT.US (4.0+1.2)% w/w ΒΤ x 2 tubes x 20 gr+1 plastic jar+1 plastic spatula | 15.38 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | ||
| Greece | Acmefront® Cut.sol (40+0.25)mg/mL Bt X 1 Bottle X 50ml (Πλαστικη Φιαλη Με Ειδικο Σταγονομετρικο Ρυγχος) | 50ml | 16.21 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ERYTIN-ACN GEL.EXT.US (4.0+0.025)% W/W BTx1 TUBE x 50 G | 50000mg | 16.21 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | ERYTIN-ACN CUT.SOL (4.0+0.025)% W/V BTx1 BOTTLE x 50 ML | 50ml | 16.21 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Acmefront® Gel (40+0.25)mg/g Bt X 1 Tube X 50g Σωληναριο Απο Συμπιεσμενο Αλουμινιο Με Εσωτερικη Επιστρωση Ρητινης Εποξυφαινολικου Τυπου Με Βιδωτο Πωμα Απο Λευκο Πολυπροπυλενιο | 50000mg | 16.21 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Abboticin | 250mg | pakki | 1,730.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Infectomycin | 400mg/5ml | glas | 3,274.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Davercin | 250mg | pakki | 4,092.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Erythrocine | 1000mg | pakki | 5,511.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Infectomycin | 400mg/5ml | fl | 6,682.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Erythrocine | 250mg | glas | 7,311.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Erythromycin | 1000mg | pakki | 29,351.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Lebanon | Erythromycin 1.5 % | 15mg/1ml | 120ml | 5.61 USD | public price (USD, Decision 119/1) | MoPH | 2026-09-02 |
| Luxembourg | ERYTHROMYCINE-BAILLEUL SOL.APP.CUT 4 PC 1*1 flacon 100 mL | 100ml | 4.06 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Erythrocine GRAN.SP.BUV. 250 mg / 5 mL 1*1 flacon HDPE 80 mL | 250mg/5ml | 10.44 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Erythroforte 500 CPR.ENROB. 500 mg 1*16 CPR.(flacon) | 500mg | 11.39 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Aknemycin SOL.APP.CUT 2 PC 1*1 flacon verre 25 mL | 25ml | 12.70 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Aknemycin POMM. 2 PC 1*1 tube alu. 25 g | 25000mg | 12.70 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | ERYTHROCINE IV PDRE SOL.PERF. 1 g 1*1 FIOLE | 1000mg | 13.97 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | ZINERYT PSV.SOL.CU 40 mg / 1 mL + 12 mg / 1 mL 1*1 flacon solvant 30 mL + 1*1 flacon poudre | 12mg/1ml+40mg/1ml | 18.87 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Norway | Ery-Max | 100mg/1ml | 50 ml | 202.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Abboticin | 250mg | 30 stk | 304.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Abboticin | 100mg/1ml | 100 ml | 305.20 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Ery-Max | 100mg/1ml | 100 ml | 305.20 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Abboticin | 1000mg | 1 g | 318.00 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Abboticin | 250mg | 40 stk | 326.10 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Ery-Max | 200mg | 20 stk | 505.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Abboticin | 250mg | 100 stk | 760.80 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Erythromycin Panpharma | 1000mg | 1 g | 1,186.30 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Saudi Arabia | Omathrocin Oral Drops 100 mg- 2.5 mL | 100mg+2.5ml | 4.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrodar | 6.20 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Erythromil 200mg-5ml Susp. | 200mg+5ml | 6.20 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Omathrocin 200 Oral Suspension | 7.05 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Oftalmolosa 0.5% | 0.5pct | 7.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrodar | 7.55 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Erythromil 250mg Tab | 250mg | 7.55 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythromil Forte 400mg-5mlsusp. | 400mg | 9.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Omathrocin 250 mg Tablet | 250mg | 9.95 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrodar 400mg Fort Tab | 400mg | 10.25 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Eromycin 250mg Tablet | 250mg | 11.05 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrocin Tab. 250 mg. | 250mg | 13.80 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrocin Granules 200mg-5ml | 200mg+5ml | 14.40 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Eromycin 200mg-5ml Susp | 200mg+5ml | 15.55 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrocin Granules 200mg-5ml | 200mg+5ml | 19.45 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrocin Tab. 500mg. | 500mg | 22.10 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erysol 2% Topical Lotion | 2pct | 22.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrocin I.v. 500mg Vial | 500mg | 22.90 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Eryc 250mg Caps | 250mg | 25.75 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Eryped For Oral Soln 400mg-5ml | 400mg+5ml | 26.65 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Zymar 0.3% Ophthalmic Solution | 200mg+5ml | 28.35 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrocin Pce 333mg Tab | 333mg | 29.90 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Eryderm For Topical Soln 2% | 2pct | 32.50 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythromycin Lactobionate 1g Iv Vial | 1000mg | 36.15 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Erythrocin I.v. 1g Vial | 1000mg | 41.55 SAR | public | SFDA | 2026-09-01 | |
| Saudi Arabia | Omathrocin | 373.20 SAR | public | SFDA | 2026-09-01 | ||
| Slovakia | Aknemycin 2000 | 25000mg | ung 1x25 g (tuba Al) | 3.50 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| Slovakia | Eryfluid | 100ml | sol der 1x100 ml (fľ.skl.hnedá) | 4.87 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
| South Africa | Eryko-250 | 250mg | 100 | 141.72 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Betamycin | 250mg | 100 | 175.61 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Eryko-250 | 250mg | 500 | 708.59 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | ETOCIN 250mg | 250mg | 500 | 846.59 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| United Arab Emirates | Eromycin ® 250mg | 250mg | 20's [10's Blister x 2] | 18.50 AED | public | EDE | 2026-08-31 |
| United Arab Emirates | Eromycin ® 250mg | 250mg | 100's [10's Blister x 10] | 39.00 AED | public | EDE | 2026-08-31 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Erythro-Med (DIN 02030578) marketed in Canada?
No. Health Canada lists DIN 02030578 as Cancelled Post Market as of 07 Jun 2022.
Who holds the Canadian licence for this product?
Bio Agri Mix Lp is the company of record in the Health Canada Drug Product Database.
Is Erythromycin (Erythromycin Phosphate) registered outside Canada?
Yes — Nexara Health has matched 478 registrations in 27 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02030578, status date 2022-06-07; national medicine registries: ANMDMR nomenclator, BDA, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, FEST (DMP), HPRA, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, MoPH, MZ SR kategorizacia, NHRA, NPRA, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02030578, status date 2022-06-07; national medicine registries: ANMDMR nomenclator, BDA, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, FEST (DMP), HPRA, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, MoPH, MZ SR kategorizacia, NHRA, NPRA, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, NHRA, PBS, SFDA.
Health Canada Drug Product Database (DPD), DIN 02030578, status date 2022-06-07; national medicine registries: ANMDMR nomenclator, BDA, CNS liste positive, DH Drug Office, DoH SEP database, eEKO (Erstattungskodex), EU national register, FEST (DMP), HPRA, HSA, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, Medicines Authority, MoH deltio timwn, MoPH, MZ SR kategorizacia, NHRA, NPRA, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, EDE, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MoPH, MZ SR kategorizacia, NHRA, PBS, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.